Finance

Lists
Why is OSE down 3,87%?
Dive Deeper
OSE:EPA
Ose Immunotherapeutics SA
1,76 €
-3,87%
(-0,071) 1D
4 ნოე, 17:35:18 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
1,85 €
High
1,85 €
Low
1,74 €
Mkt. cap
42,76 მლნ.
Avg. vol.
179,66 ათ.
Volume
257,98 ათ.
52-wk high
5,92 €
52-wk low
1,74 €
EPS
-1,69 €
Shares outstanding
23,56 მლნ.
No. of employees
64
Open
1,85 €
High
1,85 €
Low
1,74 €
Mkt. cap
42,76 მლნ.
Avg. vol.
179,66 ათ.
Volume
257,98 ათ.
52-wk high
5,92 €
52-wk low
1,74 €
EPS
-1,69 €
Shares outstanding
23,56 მლნ.
No. of employees
64
News stories
From web sources and news partners
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 ნოე. 2004
Headquarters-
Sector-
Industry-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2024
დეკ. 2024
Revenue
431,00 ათ.
431,00 ათ.
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 მლნ.
8,28 მლნ.
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 მლნ.
1,08 მლნ.
Operating expense
10,22 მლნ.
10,22 მლნ.
Total operating expenses
10,22 მლნ.
10,22 მლნ.
Operating income
-9,79 მლნ.
-9,79 მლნ.
Other non operating income
-611,00 ათ.
-611,00 ათ.
EBT including unusual items
-10,44 მლნ.
-10,44 მლნ.
EBT excluding unusual items
-10,53 მლნ.
-10,53 მლნ.
Income tax expense
-576,50 ათ.
-576,50 ათ.
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 ათ.
41,00 ათ.
Net income
-9,86 მლნ.
-9,86 მლნ.
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 ათ.
571,00 ათ.
Interest expense
-707,50 ათ.
-707,50 ათ.
Net interest expenses
-136,50 ათ.
-136,50 ათ.
Depreciation and amortization charges
-
-
EBITDA
-9,74 მლნ.
-9,74 მლნ.
Gain or loss from assets sale
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები